Information day on the joint CDTI-Carlos III Health Institute call for proposals on personalized medicine

Do you want to know the keys to the joint CDTI-ISCIII call for collaborative R&D&I projects in Personalized Medicine and Advanced Therapies?

This joint action will allocate 55 million euros from the Next Generation EU to finance collaborative R&D&I projects in health between companies, research centers and organizations in the National Health System.

It seeks to coordinate scientific and business capabilities to improve the health of the Spanish population through scientific knowledge, cutting-edge health innovation and data as vectors of transformation. The performance pursues, among others, challenges such as:

• Development and clinical implementation of portable disruptive digital solutions that respond to unmet needs in the monitoring of chronic diseases.
• Innovative processes for the production of essential drugs, other emerging drugs or vaccines.
• Development and validation of innovative tools to improve the accuracy of diagnostic imaging.
• Identification, development, and clinical validation of new biomarkers and other biotechnological techniques and/or tools aimed at improving the early diagnosis of diseases.

This action is articulated through a first expression of interest that includes the description of the joint project between companies and public research organizations and centers of the SNS, and two requests for aid to the CDTI and the ISCIII respectively, for the financing of each part of the joint project.

In order to know the keys to this call for joint action and to be able to ask questions to the main entity managing funding for companies, we invite you to an information day, exclusively for CTA companies, with Juan Luis Romera, from the Department of Institutional Promotion and Territorial Cooperation of the CDTI.